Mariagrazia Pizza

This inventor holds 82 USPTO granted patents and 37 published patent applications, plus 10 CIPO patents and 40 EPO patents, primarily in Vaccine Development (CPC class A61K39-095). Top assignees: Glaxosmithkline Biologicals Sa, Novartis Ag, Novartis Vaccines and Diagnostics Srl. Active years: 1999-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mariagrazia Pizza. Retrieved from https://idiyas.com/inventor/mariagrazia-pizza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 82 (Patent Applications = 37)

% Patents Active = 43.9

CIPO Patents = 10 (Patent Applications = 15)

EPO Patents = 40 (Patent Applications = 77)

Average Co-Inventor Count = 3.4

ph-index = 21

Forward Citations = 1,262(Granted Patents)

Forward Citations (Not Self Cited) = 802(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Company Filing History:

35 out of 545

Glaxosmithkline Biologicals Sa

Novartis Vaccines and Diagnostics Srl

patents

4. 6 out of 20

J. Craig Venter Institute

Novartis Vaccines & Diagnostics, Gmbh

J. Craig Venture Institute, Inc.

patent

where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...

Areas of Expertise:

Meningococcal Proteins

Immunogenic Compositions

Outer Membrane Vesicles

Clostridium Difficile

Adjuvanted Combinations

Antigenic Peptides

Hybrid Expression

Tandem Polypeptides

Neisserial Proteins

Serogroup Vaccines

Factor H Binding Proteins

82 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12161707 - Vaccines for (2024-12-10),

2. 12128094 - Immunogenic compositions comprising OMVs, an acellular pertussis antigen, a tetanus toxoid and a diphtheria toxoid (2024-10-29),

3. 12109259 - Vaccines for (2024-10-08),

4. 10596246 - Adjuvanted combinations of meningococcal factor H binding proteins (2020-03-24),

5. 10478483 - Combinations of meningococcal factor H binding proteins (2019-11-19),

6. 10376573 - Vaccines for serogroup X meningococcus (2019-08-13),

7. 10336794 - Immunogenic bacterial vesicles with outer membrane proteins (2019-07-02),

8. 10328142 - Multiple variants of meningococcal protein NMB1870 (2019-06-25),

9. 10195264 - Immunising against meningococcal serogroup Y using proteins (2019-02-05),

10. 10179167 - Developments in meningococcal outer membrane vesicles (2019-01-15),

11. 10105429 - [object Object] (2018-10-23),

12. 10035826 - [object Object] (2018-07-31),

13. 9932374 - Clostridium difficile polypeptides as vaccine (2018-04-03),

14. 9771399 - Immunogenic bacterial vesicles with outer membrane proteins (2017-09-26),

15. 9694063 - Clostridium difficile toxin-based vaccine (2017-07-04),

Title: Mariagrazia Pizza: A Visionary Inventor Shaping the Future of Vaccines

Introduction:

Mariagrazia Pizza, a prolific inventor hailing from Siena, Italy, is renowned for his unwavering passion for innovation and commitment to excellence. With an impressive portfolio of 79 patents, his groundbreaking work in the field of vaccines continues to influence and inspire the next generation of inventors worldwide.

Latest Patents:

Among his latest patents, one notable invention stands out: "Adjuvanted Combinations of Meningococcal Factor H Binding Proteins." This innovative solution addresses the inherent poor coverage of the M01573 sequence in meningococcal fHbp-based vaccines. By incorporating a strategic combination of family I and family III fHbp sequences adjuvanted with aluminum phosphate, Mariagrazia Pizza's invention promises a more effective and comprehensive immune response.

Career Highlights:

Throughout his distinguished career, Mariagrazia Pizza has made significant contributions in renowned companies such as GlaxoSmithKline Biologicals SA and Novartis AG. His pioneering work has not only advanced the field of vaccinology but has also paved the way for transformative breakthroughs in healthcare.

Collaborations:

Collaborating closely with esteemed colleagues such as Rino Rappuoli and Vega Masignani, Mariagrazia Pizza has fostered a culture of innovation and collaboration. Together, they have pushed the boundaries of scientific discovery, working towards a common goal of improving global health outcomes through cutting-edge vaccine technologies.

Conclusion:

In conclusion, Mariagrazia Pizza's legacy as a visionary inventor and his tireless dedication to pushing the boundaries of scientific innovation serve as a beacon of inspiration for inventors and researchers worldwide. His pioneering work in developing novel vaccine solutions underscores the vital role of creativity and ingenuity in driving positive change and shaping a better future for all.

Profile summary based on public USPTO records.